Table 3.

Association^* of Carotenoids and Retinol with Extent of Prostate Biopsy Cores Inflamed in 235 Men without Prostate Cancer and Irrespective of Indication for Biopsy^**, Placebo Arm, PCPT

		Extent of Biopsy Cores Inflamed
		None	Any		Some		All
	Tertile***	N	N	OR (95%CI)	N	OR (95%CI)	N	OR (95%CI)
β-cryptoxanthin	1	25	53	1.00	33	1.00	20	1.00
	2	12	67	2.67 (1.19,5.99)	46	2.98 (1.27,6.97)	21	2.16 (0.83,5.63)
	3	16	62	1.80 (0.84,3.82)	43	2.03 (0.91,4.53)	19	1.40 (0.55,3.53)
Lycopene	1	16	62	1.00	42	1.00	20	1.00
	2	22	57	0.56 (0.26,1.21)	38	0.57 (0.26,1.28)	19	0.54 (0.21,1.38)
	3	15	63	1.38 (0.59,3.25)	42	1.33 (0.55,3.23)	21	1.51(0.56,4.08)
α-carotene	1	19	59	1.00	37	1.00	22	1.00
	2	16	63	1.30 (0.60,2.79)	43	1.39 (0.63,3.12)	20	1.13 (0.45,2.83)
	3	18	60	1.02 (0.49,2.22)	42	1.16 (0.52,2.58)	18	0.82 (0.33,2.07)
β-carotene	1	16	62	1.00	41	1.00	21	1.00
	2	19	60	0.73 (0.33,1.58)	41	0.76 (0.34,1.72)	19	0.65 (0.26,1.66)
	3	18	60	0.81 (0.37,1.79)	40	0.83 (0.36,1.89)	20	0.79 (0.31,2.03)
Sum of these carotenoids	1	22	56	1.00	38	1.00	18	1.00
	2	13	66	1.35 (0.63,2.90)	43	1.34 (0.60,2.99)	23	1.38 (0.55,2.99)
	3	18	60	1.33 (0.61,2.90)	41	1.32 (0.58,3.00)	19	1.35 (0.53,3.49)
Retinol	1	17	61	1.00	42	1.00	19	1.00
	2	15	64	1.31 (0.59,2.89)	41	1.21 (0.53,2.78)	23	1.53 (0.60,3.92)
	3	21	57	0.78 (0.35,1.65)	39	0.75 (0.33,1.70)	18	0.77 (0.30,1.99)

^*Models adjusted for baseline age, cholesterol, race, family history prostate cancer.

^**92.8% did not have a clinical indication for biopsy

^***Tertile ranges (nmol/mL): β-cryptoxanthin: T1: 0.0139 to <0.122, T2: 0.122 to <0.203, T3: 0.203 to 0.728; lycopene: T1: 0.0700 to <0.548, T2:0.548–0.782, T3:0.786 to 1.90; α-carotene: T1:0.0169 to <0.0655, T2: 0.0655 to <0.111, T3: 0.111 to 0.894; β-carotene: T1: 0.0437 to <0.326, T2: 0.326 to <0.567, T3: 0.567 to 6.63; sum of these carotenoids: T1: 0.145 to <1.18, T2: 1.18 to <1.67, T3: 1.67–9.31; retinol: T1: 1.36 to <2.15, T2: 2.15 to <2.609, T3: 2.609 to 5.15.